APA (7th ed.) Citation

Durongpisitkul, K., Chungsomprasong, P., Vijarnsorn, C., Chanthong, P., Kanjanauthai, S., & Soongswang, J. (2021). Improved low-risk criteria scores for combination therapy of sildenafil and generic bosentan in patients with congenital heart disease with severe pulmonary hypertension: A prospective open label study. JRSM Cardiovascular Disease, 10, 1. https://doi.org/10.1177/2048004020982213

Chicago Style (17th ed.) Citation

Durongpisitkul, Kritvikrom, Paweena Chungsomprasong, Chodchanok Vijarnsorn, Prakul Chanthong, Supaluck Kanjanauthai, and Jarupim Soongswang. "Improved Low-risk Criteria Scores for Combination Therapy of Sildenafil and Generic Bosentan in Patients with Congenital Heart Disease with Severe Pulmonary Hypertension: A Prospective Open Label Study." JRSM Cardiovascular Disease 10 (2021): 1. https://doi.org/10.1177/2048004020982213.

MLA (9th ed.) Citation

Durongpisitkul, Kritvikrom, et al. "Improved Low-risk Criteria Scores for Combination Therapy of Sildenafil and Generic Bosentan in Patients with Congenital Heart Disease with Severe Pulmonary Hypertension: A Prospective Open Label Study." JRSM Cardiovascular Disease, vol. 10, 2021, p. 1, https://doi.org/10.1177/2048004020982213.